Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Increasing the value of health research in the WHO African Region beyond 2015-reflecting on the past, celebrating the present and building the future: a bibliometric analysis.

Uthman OA, Wiysonge CS, Ota MO, Nicol M, Hussey GD, Ndumbe PM, Mayosi BM.

BMJ Open. 2015 Mar 13;5(3):e006340. doi: 10.1136/bmjopen-2014-006340.

2.

Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study.

Frambo AA, Atashili J, Fon PN, Ndumbe PM.

BMC Res Notes. 2014 Jun 25;7:394. doi: 10.1186/1756-0500-7-394.

3.

Time for Option B+? Prevalence and characteristics of HIV infection among attendees of 2 antenatal clinics in Buea, Cameroon.

Takow SE, Atashili J, Enow-Tanjong R, Mesembe MT, Ikomey GM, Ndip LM, Mbuagbaw JC, Ndumbe PM.

J Int Assoc Provid AIDS Care. 2015 Jan-Feb;14(1):77-81. doi: 10.1177/2325957413510607. Epub 2013 Dec 5.

PMID:
24309753
4.

Bacteriuria amongst pregnant women in the Buea Health District, Cameroon: prevalence, predictors, antibiotic susceptibility patterns and diagnosis.

Mokube MN, Atashili J, Halle-Ekane GE, Ikomey GM, Ndumbe PM.

PLoS One. 2013 Aug 16;8(8):e71086. doi: 10.1371/journal.pone.0071086. eCollection 2013.

5.

Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.

Atashili J, Gaynes BN, Pence BW, Tayong G, Kats D, O'donnell JK, Ndumbe PM, Njamnshi AK.

BMC Neurol. 2013 Jul 15;13:86. doi: 10.1186/1471-2377-13-86.

6.

The Potentials of Fas Receptors and Ligands in Monitoring HIV-1 Disease in Children in Yaounde, Cameroon.

Ikomey G, Assoumou MC, Atashili J, Mesembe M, Mukwele B, Lyonga E, Eyoh A, Kafando A, Ndumbe PM.

J Int Assoc Provid AIDS Care. 2013 Jun 6. [Epub ahead of print]

PMID:
23744775
7.

Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.

Fokam J, Billong SC, Bissek AC, Kembou E, Milenge P, Abessouguie I, Nkwescheu AS, Tsomo Z, Aghokeng AF, Ngute GD, Ndumbe PM, Colizzi V, Elat JB.

BMC Public Health. 2013 Apr 8;13:308. doi: 10.1186/1471-2458-13-308.

8.
9.

Voluntary counseling and testing for HIV among high school students in the Tiko health district, Cameroon.

Haddison EC, Nguefack-Tsagué G, Noubom M, Mbatcham W, Ndumbe PM, Mbopi-Kéou FX.

Pan Afr Med J. 2012;13:18. Epub 2012 Sep 24.

10.

Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study.

Atashili J, Miller WC, Smith JS, Ndumbe PM, Ikomey GM, Eron J, Rinas AC, Myers E, Adimora AA.

BMC Res Notes. 2012 Oct 29;5:590. doi: 10.1186/1756-0500-5-590.

11.

Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon.

Gaynes BN, Pence BW, Atashili J, O'Donnell J, Kats D, Ndumbe PM.

PLoS One. 2012;7(7):e41699. doi: 10.1371/journal.pone.0041699. Epub 2012 Jul 31.

12.

Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon.

Pence BW, Gaynes BN, Atashili J, O'Donnell JK, Tayong G, Kats D, Whetten R, Whetten K, Njamnshi AK, Ndumbe PM.

J Affect Disord. 2012 Dec 20;143(1-3):208-13. doi: 10.1016/j.jad.2012.05.056. Epub 2012 Jul 27.

13.

Impact of malaria on hematological parameters in people living with HIV/AIDS attending the Laquintinie Hospital in Douala, Cameroon.

Tchinda GG, Atashili J, Achidi EA, Kamga HL, Njunda AL, Ndumbe PM.

PLoS One. 2012;7(7):e40553. doi: 10.1371/journal.pone.0040553. Epub 2012 Jul 10.

14.

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon.

Ikomey GM, Okomo-Assoumou MC, Atashili J, Mesembe MT, Mukwele B, Lyonga E, Eyoh A, Ndumbe PM.

BMC Res Notes. 2012 Jun 22;5:322. doi: 10.1186/1756-0500-5-322.

15.

Impact of antiretroviral therapy on glycemia and transaminase levels in patients living with HIV/AIDS in Limbe, Cameroon.

Ottop FM, Atashili J, Ndumbe PM.

J Int Assoc Provid AIDS Care. 2013 Jan-Feb;12(1):23-7. doi: 10.1177/1545109712447199. Epub 2012 Jun 13.

PMID:
22699715
16.

Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis.

Wiysonge CS, Uthman OA, Ndumbe PM, Hussey GD.

PLoS One. 2012;7(5):e37905. doi: 10.1371/journal.pone.0037905. Epub 2012 May 25.

17.

Early warning indicators for HIV drug resistance in Cameroon during the year 2010.

Billong SC, Fokam J, Nkwescheu AS, Kembou E, Milenge P, Tsomo Z, Dion GN, Aghokeng AF, Mpoudi EN, Ndumbe PM, Colizzi V, Elat Nfetam JB.

PLoS One. 2012;7(5):e36777. doi: 10.1371/journal.pone.0036777. Epub 2012 May 17.

18.

High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?

Atashili J, Adimora AA, Ndumbe PM, Ikomey GM, Rinas AC, Myers E, Eron J, Smith JS, Miller WC.

Cancer Epidemiol. 2012 Jun;36(3):263-9. doi: 10.1016/j.canep.2011.10.003. Epub 2011 Nov 1.

19.

Sexual behavior of HIV-positive women in Cameroon.

Njabanou NM, Atashili J, Mbanya D, Mbu ER, Ikomey GM, Kefie CA, Kinge TN, Etogo D, Adimora AA, Ndumbe PM.

J Int Assoc Provid AIDS Care. 2013 Mar-Apr;12(2):98-102. doi: 10.1177/1545109711421640. Epub 2011 Sep 27.

PMID:
21951727
20.

Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon.

Fokam J, Salpini R, Santoro MM, Cento V, Perno CF, Colizzi V, Ndumbe PM, Fokunang Ntungen C, Ndiang Tetang SM, Nanfack AJ, Takou Komego DA, Cappelli G.

Pediatr Infect Dis J. 2011 Dec;30(12):1062-8. doi: 10.1097/INF.0b013e31822db54c.

PMID:
21817951
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk